| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $663.4M | — | +69.1% |
| Cost of Revenue | $56.3M | — | +51.7% |
| R&D Expense | $207.2M | — | +8.4% |
| SG&A Expense | $65.5M | — | -5.6% |
| Operating Income | $182.9M | — | +4586.4% |
| Pre-tax Income | $205.7M | — | +741.9% |
| Income Tax | $1.7M | — | +201.5% |
| Net Income | $204.0M | — | +679.8% |
| EPS (Basic) | $1.07 | — | +664.3% |
| EPS (Diluted) | $1.01 | — | +676.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.37B | +44.1% | +116.2% |
| Accounts Receivable | $522.9M | -11.4% | +60.3% |
| Current Assets | $3.39B | +8.0% | +45.4% |
| Total Assets | $3.48B | +7.6% | +43.0% |
| Current Liabilities | $265.9M | -2.0% | +42.3% |
| Total Liabilities | $304.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $312.3M | — | +144.8% |
| Capital Expenditures | $1.1M | — | +11.3% |
| Investing Cash Flow | $124.8M | — | +553.9% |
| Financing Cash Flow | -$16.3M | — | +38.5% |
| Free Cash Flow | $311.2M | — | +145.8% |
| +38.5% |
| Stockholders' Equity | $3.18B | +8.6% | +43.4% |